1 of 1
Story summary
- HIV testing dropped significantly last year due to interruptions in the PEPFAR program, which has saved millions since 2003.
- Mike Reid, former PEPFAR chief science officer, criticized U.S. President Donald Trump for cutting aid.
- He also cited use of health funding as leverage for U.S. commercial interests and reduced oversight.
- The State Department said it will continue funding PEPFAR, but did not address conditional-assistance claims.
